Open Accessibility Menu

One Third of FDA Approved Drugs Experience Some Kind of Recall

Jason Reese


  • A recent FDA analysis has concluded that the sexual enhancer drug, Rhino 69 Extreme 50000 is tainted with undeclared tadalafil. The analysis has caused the drug’s wholesaler to initiate a voluntary recall.
  • Tadalafil is an active ingredient in a FDA-approved prescription drug that is used for erectile dysfunction.
  • Some Rhino 69 consumers with underlying cardiovascular diabetes, hypertension, high cholesterol or heart disease, could face fatal consequences when mixing the enhancer with regular medicines like nitrates.
  • So far, there have not been any reports of adverse events related to this recall but in 2017, the American Medical Association released a report showing that many drugs the FDA approves are involved in some kind of recall or safety event after being released to consumers.

Sexual Enhancement Drug on FDA’s Recall Watchlist

On April 18, 2018, AMA Wholesale Inc. voluntarily recalled Rhino 69 Extreme 50000 capsules at the consumer level after a U.S. Food & Drug Administration (FDA) analysis found the product to be tainted with undeclared tadalafil. Tadalafil is an active ingredient in a FDA-approved prescription drug that is used for erectile dysfunction. As of April 24, 2018, the distributor had not yet received any reports of adverse events related to this recall.

According to the FDA, “consumers who take supplements for erectile dysfunction could have underlying cardiovascular disease (from diabetes, hypertension, and others). Consumers with diabetes, hypertension, high cholesterol or heart disease often take nitrates; concomitant use of nitrates and PDE5 inhibitors can lead to fatal cardiovascular collapse.”

About the Rhino 69 Extreme 50000 Recall

Rhino 69 Extreme 50000 is used as a sexual enhancer and is packaged in single capsule, blister packs with an expiration date of 12/2022 and UPC Code: 718122071128. The product was distributed nationwide via internet sales to the customers. AMA Wholesale Inc. (Distributor/Re-seller) is notifying its customers by E-Mail and is arranging for return of the recalled product.

Consumers/distributors/retailers that have purchased ‘Rhino 69 Extreme 50000’ should immediately stop the consumption and the resale of the product and return the product to the place of purchase for a refund.

1/3 of FDA Approved Drugs Recalled From 2001 and 2010

About a third of the drugs the FDA approved between 2001 and 2010 were involved in some kind of safety event after reaching the market, according to a 2017 study published in the Journal of the American Medical Association. Additional conclusions to the study found that:

  • 222 novel therapeutics had been approved.
  • There were 123 post-market safety events involving 71 products that required FDA warning or recall action.
  • 3 were withdrawn while 61 received new boxed warnings and 59 required enhanced safety communications.

To get FDA approval, the majority of the drugs with safety events were trialed in 1,000 or fewer patients.

Have You Been Seriously Injured by a Defective Product or Dangerous Medicine?

Defective medication or health product cases are complex and often leave consumers in a vulnerable place. Whether your medicine-related injuries were caused by defectively designed or manufactured drugs, by hidden side-effects, or by inadequate warnings by drug sales representatives or medical professionals, we offer a free, no-obligation consultation to help you. Our experienced defective drug attorneys at Wagner Reese can provide you the legal support and advice you need so that you can focus on your own health and healing.

Simply give us a call today at (888) 204-8440 to schedule a free consultation or speak with us by submitting our online form and our attorneys will review your information.


Request Your Free Case Evaluation

Fill out the form below to get started or give us a call at (888) 204-8440 to speak with our legal team directly.

  • Please enter your First Name.
  • Please enter your Last Name.
  • This isn't a valid phone number.
    Please enter your phone number.
    You entered an invalid number.
  • This isn't a valid email address.
    Please enter your email address.
  • Please make a selection.
  • Please enter a message.

Our Locations

  • Indianapolis Office: 201 N. Illinois St.,
    16th Floor - South Tower

    Indianapolis, IN 46204
  • Carmel Office: 11939 N. Meridian St.
    Carmel, IN 46032
  • Evansville Office: 815 John St. Suite 110
    Evansville, IN 47713
  • Fort Wayne Office: 3201 Stellhorn Rd
    Fort Wayne, IN 46815
  • Champaign Office: 701 Devonshire Dr., Suite C17
    Champaign, IL 61820